Genetic depletion of ADAM12+ cells normalizes the tumor vasculature and decreases hypoxia and acidity, restoring antitumor immunity and blocking tumor growth in mouse models of melanoma and neuroendocrine pancreatic cancer. This evidence concerns the gene ADAM12 and pancreatic endocrine carcinoma.